DoctorsProofNPPES directory · verify at state boards

Cardiovascular Disease in Fullerton, CA

8 verified cardiovascular disease doctors in Fullerton.

Cardiologists diagnose and treat conditions of the heart and blood vessels, including heart disease, arrhythmias, and heart failure.

NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.

Verify a license at the Medical Board of California

Dr. Frank Bonavita, MD

Cardiovascular Disease

21 yrs NPPES
NPI 1366446312
2240 N HARBOR BLVD, STE 200, Fullerton, CA 92835(714) 870-4665
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $173.84 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$173.84

Total received

2

Transactions

1

Paying companies

Top paying companies

Boston Scientific Corporation$173.84

Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 51th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.

Payments to Frank Bonavita do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Paul Weinstein, MD

Cardiovascular Disease

21 yrs NPPES
NPI 1275537227
2240 N HARBOR BLVD, STE 200, Fullerton, CA 92835(714) 870-4665
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $158.91 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$158.91

Total received

3

Transactions

2

Paying companies

Top paying companies

Abbott Laboratories$118.91
Medtronic, Inc.$40.00

Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 50th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.

Payments to Paul Weinstein do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Daniel Landa, MD

Cardiovascular Disease

21 yrs NPPES
NPI 1174527139
1400 N HARBOR BLVD STE 100, Fullerton, CA 92835(714) 578-0533
NPPES public registry
CMS Open Payments· $21.34 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$21.34

Total received

1

Transactions

1

Paying companies

Top paying companies

Medtronic, Inc.$21.34

Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total is on the lower end — around the 37th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.

Payments to Daniel Landa do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Edward Lee, MD

Cardiovascular Disease

21 yrs NPPES
NPI 1568466431
100 E. VALENCIA MESA DRIVE, SUITE 206, Fullerton, CA 92835(714) 446-5050
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $619.70 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$619.70

Total received

31

Transactions

13

Paying companies

Top paying companies

sanofi-aventis U.S. LLC$86.00
NOVARTIS PHARMACEUTICALS CORPORATION$79.19
E.R. Squibb & Sons, L.L.C.$73.64
Boehringer Ingelheim Pharmaceuticals, Inc.$68.96
Amgen Inc.$64.34
Merck Sharp & Dohme LLC$49.12

Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 66th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.

Payments to Edward Lee do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Jay Han, MD

Cardiovascular Disease

21 yrs NPPES
NPI 1669468757
100 E VALENCIA MESA DR, SUITE 206, Fullerton, CA 92835(714) 446-5050
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $836.29 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$836.29

Total received

45

Transactions

15

Paying companies

Top paying companies

sanofi-aventis U.S. LLC$163.58
NOVARTIS PHARMACEUTICALS CORPORATION$143.41
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)$83.96
Merck Sharp & Dohme LLC$62.11
BIOTRONIK INC.$60.05
E.R. Squibb & Sons, L.L.C.$51.85

Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 71th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.

Payments to Jay Han do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Charles Suh, MD

Cardiovascular Disease

21 yrs NPPES
NPI 1194711184
100 E VALENCIA MESA DR STE 206, Fullerton, CA 92835(714) 446-5050
NPPES public registry
CMS Open Payments· $395.36 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$395.36

Total received

18

Transactions

10

Paying companies

Top paying companies

ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)$95.40
E.R. Squibb & Sons, L.L.C.$58.98
NOVARTIS PHARMACEUTICALS CORPORATION$47.05
Baxter Healthcare$44.74
sanofi-aventis U.S. LLC$37.28
Pfizer Inc.$33.48

Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 60th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.

Payments to Charles Suh do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Alan Borsari, MD

Cardiovascular Disease

20 yrs NPPES
NPI 1063501997
2151 N HARBOR BLVD, Fullerton, CA 92835(714) 449-4800
NPPES public registry
CMS Open Payments· No payments in 2023

Industry Payments

No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.

Dr. Amir Najafi, MD

Cardiovascular Disease

14 yrs NPPES
NPI 1992064950
100 E VALENCIA MESA DR STE 206, Fullerton, CA 92835(714) 446-5050
NPPES public registry
CMS Open Payments· $249.88 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$249.88

Total received

13

Transactions

8

Paying companies

Top paying companies

sanofi-aventis U.S. LLC$61.18
NOVARTIS PHARMACEUTICALS CORPORATION$49.00
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)$48.37
Amgen Inc.$24.05
Impulse Dynamics (USA) Inc.$22.33
Lantheus Medical Imaging, Inc.$16.66

Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 55th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.

Payments to Amir Najafi do not imply any wrongdoing. Many are meals, education, or research support.

Cardiovascular Disease in Fullerton, CA — Verified | DoctorsProof | DoctorsProof